| 臺大學術典藏 |
2020-03-05T12:32:56Z |
An unusual cause of pancreatitis
|
Lee T.-C.; Liu K.-L.; Lin J.-T.; Tien Y.-W.; TSUI-LIEN MAO; Wang H.-P. |
| 臺大學術典藏 |
2020-03-05T12:32:56Z |
Diffuse mesothelin expression correlates with prolonged patient survival in ovarian serous carcinoma
|
Yen M.J.; Hsu C.-Y.; TSUI-LIEN MAO; Wu T.-C.; Roden R.; Wang T.-L.; Shih L.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:56Z |
Notch3 gene amplification in ovarian cancer
|
Park J.T.; Li M.; Nakayama K.; TSUI-LIEN MAO; Davidson B.; Zhang Z.; Kurman R.J.; Eberhart C.G.; Shih I.-M.; Wang T.-L. |
| 臺大學術典藏 |
2020-03-05T12:32:55Z |
Immunohistochemistry of choriocarcinoma: An aid in differential diagnosis and in elucidating pathogenesis
|
TSUI-LIEN MAO; Kurman R.J.; Huang C.-C.; Lin M.-C.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:55Z |
Frequent nuclear expression of β-catenin protein but rare β-catenin mutation in pulmonary sclerosing haemangioma
|
Chiang P.-M.; Yuan R.-H.; Hsu H.-C.; TSUI-LIEN MAO; Hu R.-H.; Lai P.-L.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:55Z |
HSD3B1 as a novel trophoblast-associated marker that assists in the differential diagnosis of trophoblastic tumors and tumorlike lesions
|
Huang W.; Shih I.-M.; TSUI-LIEN MAO; Kurman R.J.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:55Z |
Low-grade serous carcinoma of the ovary displaying a macropapillary pattern of invasion
|
Yemelyanova A.; TSUI-LIEN MAO; Nakayama N.; Shih I.M.; Kurman R.J. |
| 臺大學術典藏 |
2020-03-05T12:32:54Z |
IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype
|
K?bel M.; Xu H.; Bourne P.A.; Spaulding B.O.; Shih I.-M.; TSUI-LIEN MAO; Soslow R.A.; Ewanowich C.A.; Kalloger S.E.; Mehl E.; Lee C.-H.; Huntsman D.; Gilks C.B. |
| 臺大學術典藏 |
2020-03-05T12:32:54Z |
Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas (Cancer Research (2009) 69, (4036-42))
|
Kuo K.-T.; Guan B.; Feng Y.; TSUI-LIEN MAO; Chen X.; Jinawath N.; Wang Y.; Kurman R.J.; Shih I.-M.; Wang T.-L. |
| 臺大學術典藏 |
2020-03-05T12:32:54Z |
Cystic and adenofibromatous clear cell carcinomas of the ovary: Distinctive tumors that differ in their pathogenesis and behavior: A clinicopathologic analysis of 122 cases
|
Veras E.; TSUI-LIEN MAO; Ayhan A.; Ueda S.; Lai H.; Hayran M.; Shih I.-M.; Kurman R.J. |
| 臺大學術典藏 |
2020-03-05T12:32:54Z |
Analysis of DNA copy number alterations in Ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas
|
Kuo K.-T.; Guan B.; Feng Y.; TSUI-LIEN MAO; Chen X.; Jinawath N.; Wang Y.; Kurman R.J.; Shih I.-M.; Wang T.-L. |
| 臺大學術典藏 |
2020-03-05T12:32:54Z |
Trophoblastic neoplasms express fatty acid synthase, which may be a therapeutic target via its inhibitor C93
|
Ueda S.M.; TSUI-LIEN MAO; Kuhajda F.P.; Vasoontara C.; Giuntoli R.L.; Bristow R.E.; Kurman R.J.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:54Z |
Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma
|
Kuo K.-T.; TSUI-LIEN MAO; Jones S.; Veras E.; Ayhan A.; Wang T.-L.; Glas R.; Slamon D.; Velculescu V.E.; Kuman R.J.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:53Z |
Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma
|
Jones S.; Wang T.-L.; Shih I.-M.; TSUI-LIEN MAO; Nakayama K.; Roden R.; Glas R.; Slamon D.; Diaz Jr. L.A.; Vogelstein B.; Kinzler K.W.; Velculescu V.E.; Papadopoulos N. |
| 臺大學術典藏 |
2020-03-05T12:32:53Z |
Clinicopathological significance of loss of ARID1A immunoreactivity in ovarian clear cell carcinoma
|
Maeda D.; TSUI-LIEN MAO; Fukayama M.; Nakagawa S.; Yano T.; Taketani Y.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:53Z |
DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma
|
Kuo K.-T.; TSUI-LIEN MAO; Chen X.; Feng Y.; Nakayama K.; Wang Y.; Glas R.; Ma M.J.; Kurman R.J.; Shih I.-M.; Wang T.-L. |
| 臺大學術典藏 |
2020-03-05T12:32:53Z |
Lack of a Y-chromosomal complement in the majority of gestational trophoblastic neoplasms
|
Yap K.L.; Hafez M.J.; TSUI-LIEN MAO; Kurman R.J.; Murphy K.M.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:53Z |
Advances in the diagnosis of gestational trophoblastic tumors and tumor-like lesions
|
TSUI-LIEN MAO; Shih I.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:52Z |
Somatic mutations of PPP2R1A in ovarian and uterine carcinomas
|
Shih I.-M.; Panuganti P.K.; Kuo K.-T.; TSUI-LIEN MAO; Kuhn E.; Jones S.; Velculescu V.E.; Kurman R.J.; Wang T.-L. |
| 臺大學術典藏 |
2020-03-05T12:32:52Z |
Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A
|
Wu C.H.; TSUI-LIEN MAO; Vang R.; Ayhan A.; Wang T.-L.; Kurman R.J.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:52Z |
Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways
|
Chang M.-C.; Chen C.-A.; Chen P.-J.; Chiang Y.-C.; Chen Y.-L.; TSUI-LIEN MAO; Lin H.-W.; Lin Chiang W.-H.; Cheng W.-F. |
| 臺大學術典藏 |
2020-03-05T12:32:52Z |
Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma
|
Guan B.; TSUI-LIEN MAO; Panuganti P.K.; Kuhn E.; Kurman R.J.; Maeda D.; Chen E.; Jeng Y.-M.; Wang T.-L.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:51Z |
Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma
|
Ayhan A.; TSUI-LIEN MAO; Seckin T.; Wu C.-H.; Guan B.; Ogawa H.; Futagami M.; Mizukami H.; Yokoyama Y.; Kurman R.J.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:51Z |
Underexpression of hepatocyte nuclear factor-1β in chromophobe renal cell carcinoma
|
Wang C.-C.; TSUI-LIEN MAO; Yang W.-C.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:51Z |
HSD3B1 Is a specific trophoblast-associated marker not expressed in a wide spectrum of tumors
|
Chou Y.-Y.; Jeng Y.-M.; TSUI-LIEN MAO |
| 臺大學術典藏 |
2020-03-05T12:32:51Z |
Utility of hepatocyte nuclear factor-1β as a diagnostic marker in ovarian carcinomas with clear cells
|
Kao Y.-C.; Lin M.-C.; Lin W.-C.; Jeng Y.-M.; TSUI-LIEN MAO |
| 臺大學術典藏 |
2020-03-05T12:32:51Z |
Kr?ppel-like factor 10 expression as a prognostic indicator for pancreatic adenocarcinoma
|
Chang V.H.S.; Chu P.-Y.; Peng S.-L.; TSUI-LIEN MAO; Shan Y.-S.; Hsu C.-F.; Lin C.-Y.; Tsai K.K.C.; Yu W.C.Y.; Ch'Ang H.-J. |
| 臺大學術典藏 |
2020-03-05T12:32:50Z |
Ileum and colon perforation following peritoneal dialysis-related peritonitis and high-dose calcium polystyrene sulfonate
|
Kao C.-C.; Tsai Y.-C.; Chiang W.-C.; TSUI-LIEN MAO; Kao T.-W. |
| 臺大學術典藏 |
2020-03-05T12:32:50Z |
The roles of ARID1A in gynecologic cancer
|
TSUI-LIEN MAO; Shih I.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:50Z |
Loss of ARID1A expression correlates with stages of tumor progression in uterine endometrioid carcinoma
|
TSUI-LIEN MAO; Ardighieri L.; Ayhan A.; Kuo K.-T.; Wu C.-H.; Wang T.-L.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:49Z |
Immunohistochemical study of endometrial high-grade endometrioid carcinoma with or without a concurrent low-grade component: Implications for pathogenetic and survival differences
|
TSUI-LIEN MAO; Ayhan A.; Kuo K.-T.; Lin M.-C.; Tseng L.-H.; Ogawa H. |
| 臺大學術典藏 |
2020-03-05T12:32:49Z |
Iron suppresses ovarian granulosa cell proliferation and arrests cell cycle through regulating p38 mitogen-activated protein kinase/p53/p21 pathway
|
Chen M.-J.; Chou C.-H.; Shun C.-T.; TSUI-LIEN MAO; Wen W.-F.; Chen C.-D.; Chen S.-U.; Yang Y.-S.; Ho H.-N. |
| 臺大學術典藏 |
2020-03-05T12:32:49Z |
Gastric-type adenocarcinoma in situ of uterine cervix: cytological and histopathological features of two cases
|
Yuan C.-T.; Lin M.-C.; Kuo K.-T.; Wang T.-H.; TSUI-LIEN MAO |
| 臺大學術典藏 |
2020-03-05T12:32:49Z |
Loss of switch/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas
|
Chow C.; McAlpine J.; Kuo K.-T.; TSUI-LIEN MAO; Djordjevic B.; Soslow R.A.; Huntsman D.G.; Blake Gilks C.; K?bel M.; Lee C.-H.; Li X.; Irving J.; Meng B.; Tessier-Cloutier B.; Almadani N.; Ravn S.; Coatham M.; Hoang L.N.; Karnezis A.N. |
| 臺大學術典藏 |
2020-03-05T12:32:48Z |
Frequent CTNNB1 or PIK3CA mutations occurred in endometrial endometrioid adenocarcinoma with high levels of microsatellite instability and loss of MSH2/MSH6 expression
|
Lin M.-C.; TSUI-LIEN MAO; Kuo K.-T.; Huang H.-N.; Kuo C.-W. |
| 臺大學術典藏 |
2020-03-05T12:32:48Z |
CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis
|
Ayhan A.; Kuhn E.; Wu R.-C.; Ogawa H.; Bahadirli-Talbott A.; TSUI-LIEN MAO; Sugimura H.; Shih I.-M.; Wang T.-L. |
| 臺大學術典藏 |
2020-03-05T12:32:48Z |
Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer
|
TSUI-LIEN MAO; Fan K.F.; Liu C.L. |
| 臺大學術典藏 |
2020-03-05T12:32:48Z |
Cervical Papanicolaou Smears in Hematopoietic Stem Cell Transplant Recipients: High Prevalence of Therapy-Related Atypia during the Acute Phase
|
Ko B.-S.; Liu J.-H.; Lin C.-T.; Kuo K.-T.; TSUI-LIEN MAO; Lee Y.-H.; Tang J.-L.; Li C.-C.; Yu S.-C.; Huang H.-H.; Yao M. |
| 臺大學術典藏 |
2020-03-05T12:32:47Z |
Primary ovarian mucinous carcinoid tumor: A case report and review of literature
|
Hsu W.-W.; TSUI-LIEN MAO; Chen C.-H. |
| 臺大學術典藏 |
2020-03-05T12:32:47Z |
Ex vivo expanded human Vγ9vδ2 T-cells can suppress epithelial ovarian cancer cell growth
|
Mao T.L.; TSUI-LIEN MAO; Liao Y.J.; Chen Y.J.; Yeh C.Y.; Liu C.L. |
| 臺大學術典藏 |
2020-03-05T12:32:47Z |
SRPX and HMCN1 regulate cancer?associated fibroblasts to promote the invasiveness of ovarian carcinoma
|
Liu C.L.; Pan H.W.; Torng P.L.; Fan M.H.; TSUI-LIEN MAO |
| 臺大學術典藏 |
2019-04-24T03:56:20Z |
Immunohistochemical study of endometrial high-grade endometrioid carcinoma with or without a concurrent low-grade component: implications for pathogenetic and survival differences
|
Ogawa, Hiroshi;Lin, Ming-Chieh;Kuo, Kuang-Ting;Ayhan, Ayse;LI-HUI TSENG;TSUI-LIEN MAO; TSUI-LIEN MAO; Ayhan, Ayse; Kuo, Kuang-Ting; Lin, Ming-Chieh; LI-HUI TSENG; Ogawa, Hiroshi |
| 臺大學術典藏 |
2017 |
CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis
|
Wang T.-L.; Shih I.-M.; Sugimura H.; TSUI-LIEN MAO; Bahadirli-Talbott A.; Ogawa H.; Wu R.-C.; Kuhn E.; Ayhan A.; Ayhan A.;Kuhn E.;Wu R.-C.;Ogawa H.;Bahadirli-Talbott A.;Tsui-Lien Mao;Sugimura H.;Shih I.-M.;Wang T.-L. |
| 臺大學術典藏 |
2016 |
Loss of switch/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas
|
Lee C.-H.; Köbel M.; Hoang L.N.; Coatham M.; Ravn S.; Almadani N.; Tessier-Cloutier B.; Irving J.; Meng B.; Li X.; Chow C.; McAlpine J.; Kuo K.-T.; TSUI-LIEN MAO; Djordjevic B.; Soslow R.A.; Huntsman D.G.; Blake Gilks C.; Karnezis A.N. |
| 臺大學術典藏 |
2015 |
Immunohistochemical study of endometrial high-grade endometrioid carcinoma with or without a concurrent low-grade component: Implications for pathogenetic and survival differences
|
Tsui-Lien Mao;Ayhan A.;Kuo K.-T.;Lin M.-C.;Tseng L.-H.;Ogawa H.; TSUI-LIEN MAO; Ayhan A.; Kuo K.-T.; Lin M.-C.; Tseng L.-H.; Ogawa H. |
| 臺大學術典藏 |
2015 |
Increased proliferation in atypical hyperplasia/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors
|
Ayhan A.; TSUI-LIEN MAO; Suryo Rahmanto Y.; Zeppernick F.; Ogawa H.; Wu R.-C.; Wang T.-L.; Shih I.-M. |
| 臺大學術典藏 |
2012 |
Utility of hepatocyte nuclear factor-1β as a diagnostic marker in ovarian carcinomas with clear cells
|
Kao Y.-C.; Lin M.-C.; Lin W.-C.; Jeng Y.-M.; TSUI-LIEN MAO |
| 臺大學術典藏 |
2012 |
Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma
|
Ayhan A.; TSUI-LIEN MAO; Seckin T.; Wu C.-H.; Guan B.; Ogawa H.; Futagami M.; Mizukami H.; Yokoyama Y.; Kurman R.J.; Shih I.-M. |
| 臺大學術典藏 |
2012 |
Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways
|
Chang M.-C.;Chen C.-A.;Chen P.-J.;Chiang Y.-C.;Chen Y.-L.;Tsui-Lien Mao;Lin H.-W.;Lin Chiang W.-H.;Cheng W.-F.; Chang M.-C.; Chen C.-A.; Chen P.-J.; Chiang Y.-C.; Chen Y.-L.; TSUI-LIEN MAO; Lin H.-W.; Lin Chiang W.-H.; Cheng W.-F. |
| 臺大學術典藏 |
2011 |
The Association of Infrared Imaging Findings of the Breast with Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Status of Breast Cancer
|
Wang J.; Shih T.T.F.; Yen R.-F.; Lu Y.-S.; Chen C.-Y.; TSUI-LIEN MAO; Lin C.-H.; Kuo W.-H.; Tsai Y.-S.; Chang K.-J.; Chien K.-L. |
